EGFR and neoplasm: Previously, we showed our custom-designed cationic lipid MB could deliver EGFR siRNA to SCC-VII tumor cells using a diagnostic US pulse available on a clinical system, trigger target gene silencing, and induce tumor growth inhibition 19.